Stringent regulatory norms, having to operate in tight schedules and revenue cuts are factors affecting the drug discovery and development industry. Every year, pharmaceutical companies spend millions of dollars to test and develop new drugs, cost-cutting at these companies has made it hard to secure funds to test and deliver new medication products. The pharmaceutical industry is now employing new strategies to improve productivity in research and development.
Data analytics companies and solution providers are now working along with the pharmaceutical industry, to offer insights and solutions that help improve and increase productivity during drug research and testing, while also cutting the costs incurred in the process. The use of Data Management Systems (DMS), Manufacturing Execution Systems (MES), bioinformatics, to name a few, in the pharmaceutical industry, has changed the way they store and analyze data during drug discovery and development. The pharmaceutical companies that adopted these modern methods are already reporting increased productivity and budgets that are easier on the pocket.
This edition of Pharma Tech Outlook aims to give the readers an insight on drug discovery and development solution providers that have demonstrated strong capabilities in helping organizations navigate this sophisticated trade. A distinguished panel of CIOs, CEOs, VCs, analysts and the editorial board of Pharma Tech Outlook have come together to find the top 10 companies.
We present to you Pharma Tech Outlook’s “Top 10 Drug Discovery and Development consulting/services companies - 2018.”